Fig. 9

Associations between the 5 significant ARGs and clinical features. a–d Association between BMF expression level and age, gender, grade, and stage. e Association between LGALS3 expression level and pathology stage. f Association between PPP2R5B expression level and pathology stage. g Risk score and age. h and i Association between SQSTM1 expression level, age, and gender. j and k Association between TOP2A expression level, grade, and pathology stage